Prisoners' attitudes toward Hepatitis B vaccination

Preventive Medicine

Volumn 38, Issue 6, 2004, Pages 828-833

  Vallabhaneni, Snigdha ^a   Macalino, Grace E ^a   Reinert, Steven E ^b   Schwartzapfel, Beth ^c   Wolf, Francis A ^c   Rich, Josiah D ^a,c  

^a BROWN UNIVERSITY   (United States)

^b Lifespan   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

Hepatitis B vaccination; Injection; Injection drug use; Prisoners; Sexual risk; Sexually transmitted disease; Vaccine acceptance

Indexed keywords

HEPATITIS VACCINE;

ADULT; ARTICLE; ATTITUDE; CONTROLLED STUDY; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HEPATITIS B; HUMAN; INTERVIEW; MALE; PRIORITY JOURNAL; PRISONER; RISK FACTOR; SEXUAL BEHAVIOR; VACCINATION;

ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; PRISONERS; QUESTIONNAIRES; RANDOM ALLOCATION; RHODE ISLAND; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 2942581404     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2003.12.024     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention Achievements in public health: hepatitis B vaccination - United States 1982-2002. MMWR. 51(25):2002;549-552
2. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5125a3.htm:2003;. [Accessed March 28]
3. Centers for Disease Control and Prevention Prevention and control of infections with hepatitis viruses in correctional settings. MMWR. 52(RR1):2003;1-36
4. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5201a1.htm:2003;. [Accessed March 28]
5. Centers for Disease Control and Prevention Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee. MMWR. 40(RR-13):1991;1-19
6. http://www.cdc.gov/mmwr/preview/mmwrhtml/00033405.htm:2003;. [Accessed March 28]
7. Centers for Disease Control and Prevention Recommendation of the Immunization Practices Advisory Committee (ACIP): inactivated hepatitis B virus vaccine. MMWR. 31(24):1982;317-322
8. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001116.htm:2003;. [Accessed March 28]
9. Mahoney F.J., Stewart K., Hu H., Coleman P., Alter M.J. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch. Intern. Med. 157(22):1997;2601-2605
10. Glaser J.B., Greifinger R.B. Correctional health care: a public health opportunity. Ann. Intern. Med. 118(2):1993;139-145
11. Anda R.F., Perlman S.B., D'Alessio D.J., Davis J.P., Dodson V.N. Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am. J. Public Health. 75(10):1985;1182-1185
12. Decker M.D., Vaughn W.K., Brodie J.S., Hutcheson R.H. Jr., Schaffner W. The incidence of hepatitis B in Tennessee prisoners. J. Infect. Dis. 152(1):1985;214-217
13. Hull H.F., Lyons L.H., Mann J.M., Hadler S.C., Steece R., Skeels M.R. Incidence of hepatitis B in the penitentiary of New Mexico. Am. J. Public Health. 75(10):1985;1213-1214
14. Macalino G.E., Vlahov D., Sanford S., Patel S., Sabin K., Salas C., et al. Prevalence and incidence of human immunodeficiency virus, Hepatitis B and C virus infections among males in Rhode Island prisons. Am. J. Public Health. 94(5):2004 (May)
15. Goldstein S.T., Alter M.J., Williams I.T., et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J. Infect. Dis. 185(6):2002;713-719
16. Charuvastra A., Stein J., Schwartzapfel B., et al. Hepatitis B vaccination practices in state and federal prisons. Public Health Rep. 116(3):2001;203-209
17. Rotily M., Vernay-Vaisse C., Bourliere M., Galinier-Pujol A., Rousseau S., Obadia Y. HBV and HIV screening, and hepatitis B immunization programme in the prison of Marseille France. Int. J. STD AIDS. 8(12):1997;753-759
18. Bayas J.M., Bruguera M., Martin V., Vidal J., Rodes J., Salleras L.Y. Hepatitis B vaccination in prisons: the Catalonian experience. Vaccine. 11(14):1993;1441-1444
19. Centers for Disease Control and Prevention Update: recommendations to prevent hepatitis B virus transmission - United States. MMWR. 48:1999;33-34
20. http://www.cdc.gov/mmwr/preview/mmwrhtml/00056293.htm:2003;. [Accessed February 24]
21. Garfein R.S., Vlahov D., Galai N., Doherty M.C., Nelson K.E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Public Health. 86(5):1996;655-661
22. Alter M.J. Protecting future generations through immunization against hepatitis B. Ann. Intern. Med. 135(9):2001;835-836
23. Lollis C.M., Strothers H.S., Chitwood D.D., McGhee M. Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior? J. Behav. Med. 23(6):2000;545-557
24. Schwartzapfel B., Clarke J., Shepardson S., Sanford-Colby S., Pomposelli J., Dornhecker G., et al. Implementing routine hepatitis B vaccination at the Rhode Island Department of Corrections (RIDOC) Women's Division. Presentation at the 131st Annual Meeting (November 15-19, 2003) of American Public Health Association. 2003;. Abstract #68707; Available at http://apha.confex.com/apha/ 131am/techprogram/paper_68707.htm.
25. Bureau of Justice Statistics. Prison and Jail Inmates at Midyear 2002, NCJ 198877. Online at http://www.ojp.usdoj.gov/bjs/abstract/pjim02.htm. Accessed December 15, 2003.
26. Centers for Disease Control and Prevention Hepatitis B outbreak in state correctional facility, 2000. MMWR. 50(25):2001;529-532
27. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5025a1.htm:2003;. [Accessed March 10]
28. Spaulding A., Greene C., Davidson K., Schneidermann M., Rich J. Hepatitis C in state correctional facilities. Prev. Med. 28(1):1999;92-100
29. National Institutes of Health. NIH Consensus Development Panel on the Management of Hepatitis C: 2002. Available at: http://www.nlm.nih.gov/pubs/cbm/ hepatitis_c_2002.pdf. Accessed April 20, 2003.
30. Thio C.L., Seaberg E.C., Skolasky R. Jr., Phair J., Visscher B., Munoz A., et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 360(9349):2002;1921-1926
31. Glaser J.B., Greifinger R.B. Correctional health care: a public health opportunity. Ann. Intern. Med. 118(2):1993;139-145
32. National Commission on Correctional Healthcare Health status of soon-to-be-released inmates: a report to Congress. vol. 1:2002;National Commission on Correctional Healthcare, Washington, DC
33. http://www.ncchc.org/stbr/Volume1/Health%20Status%20(vol%201).pdf:2003;. Accessed February 24
34. Macalino G.E., Salas C.M., Towe C.W., et al. Incidence and community prevalence of HIV and other blood borne pathogens among incarcerated women in Rhode Island. Presentation at 1999 National HIV Prevention Conference:1999;. Abstract 610
35. Pisu M., Meltzer M.I., Lyerla R. Cost-effectiveness of hepatitis B vaccination of prison inmates. Vaccine. 21(3-4):2002;312-321
36. Hagan H., Thiede H., McGough J.P., Alexander E.R. Hepatitis B vaccination among research participants, Seattle, Washington. Am. J. Public Health. 92(11):2002;1756
37. Centers for Disease Control and Prevention 1998 guidelines for treatment of STDs. MMWR. 23(47)(RR-1):1998;103
38. http://www.cdc.gov/mmwr/preview/mmwrhtml/00050909.htm:2003;. [Accessed March 1]
39. Rich J., Ching C., Lally M., Gaitanis M., Schwartzapfel B., Charuvastra A., et al. A review of the case for hepatitis B vaccination of high-risk adults. Am. J. Med. 114(4):2003;316-318